G Russell Warnick

Summary

Publications

  1. ncbi High-density lipoproteins: the neglected stepchildren whose importance as a risk factor continues to be defined
    G Russell Warnick
    Berkeley HeartLab, Alameda, CA, USA
    Clin Chem 54:923-4. 2008
  2. ncbi Fasting versus nonfasting triglycerides: implications for laboratory measurements
    G Russell Warnick
    Berkeley HeartLab, 960 Atlantic Avenue, Alameda, CA 94501, USA
    Clin Chem 54:14-6. 2008
  3. ncbi Polyacrylamide gradient gel electrophoresis of lipoprotein subclasses
    G Russell Warnick
    Berkeley HeartLab Inc, 960 Atlantic Avenue, Suite 100 Alameda, CA 94501, USA
    Clin Lab Med 26:803-46. 2006
  4. ncbi Estimation of LDL-associated apolipoprotein B from measurements of triglycerides and total apolipoprotein B
    Arthur M Baca
    Berkeley HeartLab Inc, Alameda, CA 94501, USA
    Clin Chem 54:907-10. 2008
  5. ncbi Lipoprotein-associated phospholipase A2: review and recommendation of a clinical cut point for adults
    Richard B Lanman
    diaDexus, Inc, South San Francisco, CA 94080, USA
    Prev Cardiol 9:138-43. 2006
  6. ncbi A brief history of lipid and lipoprotein measurements and their contribution to clinical chemistry
    Judith R McNamara
    Lipid Research Laboratory, New England Medical Center, Tufts University, Boston, MA, USA
    Clin Chim Acta 369:158-67. 2006
  7. ncbi CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group
    Gary L Myers
    Circulation 110:e545-9. 2004
  8. ncbi Clinical Chemistry journal has contributed to progress in lipid and lipoprotein testing for fifty years
    Nader Rifai
    Children's Hospital, Department of Laboratory Medicine, Boston, MA 02115, USA
    Clin Chem 50:1861-70. 2004
  9. ncbi Quality specifications and the assessment of the biochemical risk of atherosclerosis
    Nader Rifai
    Children s Hospital, Boston, MA 02115, USA
    Clin Chim Acta 346:55-64. 2004
  10. ncbi Lack of agreement of homogeneous assays with the reference method for LDL-cholesterol may not indicate unreliable prediction of risk for cardiovascular disease
    G Russell Warnick
    Clin Chem 48:1812-4; author reply 1814-5. 2002

Collaborators

Detail Information

Publications12

  1. ncbi High-density lipoproteins: the neglected stepchildren whose importance as a risk factor continues to be defined
    G Russell Warnick
    Berkeley HeartLab, Alameda, CA, USA
    Clin Chem 54:923-4. 2008
  2. ncbi Fasting versus nonfasting triglycerides: implications for laboratory measurements
    G Russell Warnick
    Berkeley HeartLab, 960 Atlantic Avenue, Alameda, CA 94501, USA
    Clin Chem 54:14-6. 2008
  3. ncbi Polyacrylamide gradient gel electrophoresis of lipoprotein subclasses
    G Russell Warnick
    Berkeley HeartLab Inc, 960 Atlantic Avenue, Suite 100 Alameda, CA 94501, USA
    Clin Lab Med 26:803-46. 2006
    ....
  4. ncbi Estimation of LDL-associated apolipoprotein B from measurements of triglycerides and total apolipoprotein B
    Arthur M Baca
    Berkeley HeartLab Inc, Alameda, CA 94501, USA
    Clin Chem 54:907-10. 2008
    ..Ultracentrifugation of samples enriched in chylomicrons and VLDL and subsequent measurement of apo B in the infranate fraction [density (d) = 1.006] removes this interference. This apo B fraction is called "LDL-apo B."..
  5. ncbi Lipoprotein-associated phospholipase A2: review and recommendation of a clinical cut point for adults
    Richard B Lanman
    diaDexus, Inc, South San Francisco, CA 94080, USA
    Prev Cardiol 9:138-43. 2006
    ....
  6. ncbi A brief history of lipid and lipoprotein measurements and their contribution to clinical chemistry
    Judith R McNamara
    Lipid Research Laboratory, New England Medical Center, Tufts University, Boston, MA, USA
    Clin Chim Acta 369:158-67. 2006
    ....
  7. ncbi CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group
    Gary L Myers
    Circulation 110:e545-9. 2004
  8. ncbi Clinical Chemistry journal has contributed to progress in lipid and lipoprotein testing for fifty years
    Nader Rifai
    Children's Hospital, Department of Laboratory Medicine, Boston, MA 02115, USA
    Clin Chem 50:1861-70. 2004
  9. ncbi Quality specifications and the assessment of the biochemical risk of atherosclerosis
    Nader Rifai
    Children s Hospital, Boston, MA 02115, USA
    Clin Chim Acta 346:55-64. 2004
    ....
  10. ncbi Lack of agreement of homogeneous assays with the reference method for LDL-cholesterol may not indicate unreliable prediction of risk for cardiovascular disease
    G Russell Warnick
    Clin Chem 48:1812-4; author reply 1814-5. 2002
  11. ncbi Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation
    Matthias Nauck
    Department of Clinical Chemistry, University Hospital, D 79106 Freiburg, Germany
    Clin Chem 48:236-54. 2002
    ..We critically examine here the new homogeneous assays for direct determination of LDL-C...
  12. ncbi Impact of the third cholesterol report from the adult treatment panel of the national cholesterol education program on the clinical laboratory
    G Russell Warnick
    Pacific Biometrics Research Foundation, 24415 SE 156 St, Issaquah, WA 98027, USA
    Clin Chem 48:11-7. 2002
    ..The implications for clinical laboratories are summarized in this report...